Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
What fueled the previous growth in the morphine drugs market?
The market size for morphine drugs has seen robust growth in the past few years. The market, valued at $21.82 billion in 2024, is expected to climb to $23.31 billion in 2025, marking a compound annual growth rate (CAGR) of 6.9%. Factors such as an increase in cancer instances, prevalence of orthopedic diseases, a surge in surgical procedures, a growing aging population, and a rise in healthcare spending have all contributed to this growth in the historical period.
What will be the morphine drugs market size in the future?
We predict considerable expansion in the morphine drugs market in the forthcoming years, with projections pointing towards a surge to $29.99 billion in 2029, boasting a compound annual growth rate (CAGR) of 6.5%. This development in the forecasted period can be tied to the escalation in cancer diagnosis, higher prevalence of pain-associated conditions, amplified understanding of palliative treatments, an increased number of chronic diseases and the augmented usage of opioids. Major forecasted trends point towards technological progress in drug formulation, the inclusion of digital health solutions and technology, cooperation and partnerships, as well as the introduction of implantable medical instruments.
Get your morphine drugs market report here!
https://www.thebusinessresearchcompany.com/report/morphine-drugs-global-market-report
What main drivers are fueling expansion in the morphine drugs market?
The anticipated expansion of the morphine drug market can be attributed to the escalating incidence of chronic pain conditions. Chronic pain, a complicated condition typified by continuous discomfort enduring for an extended timeframe, acts as an alarm for injuries or sickness. Various intertwined factors such as aging demographics, burgeoning obesity levels, inactive lifestyles, stress and mental health conditions and environmental influences have made chronic pain a pressing global health issue. Morphine is a crucial weapon in the fight against chronic pain due to its high efficacy in pain alleviation and its potential for customization to suit the unique needs of every patient. It significantly enhances the quality of life and empowers individuals afflicted with chronic pain to accomplish more without having to endure constant excruciating pain. For example, the Government of Canada, a federal administration based in Canada, projected in May 2021 that by 2025, as many as 8.3 million Canadians could be suffering from chronic pain and this figure is projected to escalate to around 9.0 million by 2030. Thus, the rising occurrence of chronic pain conditions is fueling the growth of the morphine drug market.
What key areas define the segmentation of the global morphine drugs market?
The morphine drugs market covered in this report is segmented –
1) By Dosage form: Injectable, Oral, Other Dosage Forms
2) By Distribution channels: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
3) By Applications: Pain Management, Palliative Care, Diarrhea Suppressant, Anesthesia, Cold And Cough Suppressant, Other Applications
4) By End Users: Hospitals And Clinics, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Injectable: Morphine Sulfate Injection, Morphine Hydrochloride Injection, Morphine Extended Release Injection
2) By Oral: Oral Tablets ( Immediate-Release, Extended-Release), Oral Solution Or syrup, Oral Capsules (Extended-Release Capsules)
3) By Other Dosage Forms: Rectal Suppositories, Transdermal Patches, Sublingual Tablets Or Films
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15611&type=smp
Who are the dominant players expanding their reach in the morphine drugs market?
Major companies operating in the morphine drugs market are Pfizer Inc., Sanofi S.A., Rusan Pharma Ltd., Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Sandoz AG, Viatris Inc., Dr. Reddy’s Laboratories Ltd., Apotex Inc., Hikma Pharmaceuticals PLC, Endo Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Johnson Matthey Fine Chemicals, Fresenius Kabi USA LLC, Delpharm SaS, Alvogen Inc., Mallinckrodt Pharmaceuticals, Lannett Company, Mayne Pharma Group Limited, Noramco Inc., Tasmanian Alkaloids, Napp Pharmaceuticals Limited, Alcaliber SA
What emerging trends are influencing the growth of the morphine drugs market?
A growing emphasis is placed on the development of morphine sulfate injections by leading corporations in the morphine drug sector, in an effort to enhance medical treatment options. Morphine sulfate injection serves as a robust opioid analgesic for serious pain management. Derived from opium, it functions by connecting to opioid receptors in different parts of the brain and spinal cord, thereby modifying the perception and emotional reaction to discomfort. For instance, Morphine Sulfate Injection, an opioid agonist suitable for the treatment of severe pain needing an opioid analgesic and in cases where alternative treatments are insufficient, has been introduced by Hospira, an American pharmaceutical and medical equipment company. This product comes with varied strengths and mixtures and features a preservative-free edition for intravenous, epidural, or intrathecal application. The label details of the product underline the risks tied to the Morphine Sulfate Injection, that involve addiction, misuse, and abuse, along with crucial and life-threatening risks that could come about from its utilization.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15611
Which regions are emerging as leaders in the morphine drugs market?
North America was the largest region in the morphine drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the morphine drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Fertility Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/fertility-drugs-global-market-report
Multiple Sclerosis Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/multiple-sclerosis-drugs-global-market-report
Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor Drugs Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
